We found that RES exerts its anti-bladder cancer effect by activating the ferroptosis pathway linked with oxidation-caused damages such as mitochondrial dysfunction, lipid peroxidation, and downregulation of GPX4 and xCT proteins. Here, SLC7A11 is linked to urinary bladder carcinoma.